Guggenheim Capital LLC Acelrx Pharmaceuticals Inc Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$2.13 - $4.2 $22,854 - $45,066	-10,730 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.7 - $2.35 $110 - $152	65 Added 0.61%	10,730 $23,000
Q4 2017 Feb 14, 2018	SELL	$1.75 - $5.5 $2,331 - $7,326	-1,332 Reduced 11.1%	10,665 $22,000
Q3 2017 Nov 14, 2017	BUY	$2.9 - $4.6 $34,791 - $55,186	11,997	11,997 $55,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.